Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2006 June;58(2) > Minerva Urologica e Nefrologica 2006 June;58(2):117-31

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2006 June;58(2):117-31

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Cardiovascular disease in end stage renal disease

Sharma R. 1, Pellerin D. 2, Brecker S. J. D. 3

1 Department of Cardiology, Southampton University Hospital, Southampton, UK 2 The Heart Hospital, London, UK 3 Department of Cardiology St Georges Hospital, London, UK


PDF  


Cardiovascular disease is common and is the major cause of mortality and morbidity in end stage renal disease (ESRD). This article explores some of the many factors responsible for the high prevalence and mortality of cardiac disease in patients with ESRD. The mechanisms for cardiotoxicity in ESRD are multiple and include coronary artery disease, cardiomyopathy, microvascular disease, arrhythmia, valvular disease, cardiac calcification, pericarditis, aortic stiffness, malnutrition, inflammation, abnormal myocardial metabolism. Identifying high-risk patients remains a challenge as many traditional risk factors and screening tools are less predictive of cardiac disease in ESRD. At present, the treatment of high-risk patients is largely based on data from the general population and observational studies of patients with ESRD.

top of page

Publication History

Cite this article as

Corresponding author e-mail